Clinical Trial Update: Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating multiple-dose REMD-477 for efficacy, safety, and pharmacodynamics in adults with Type 1 diabetes mellitus; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• REMD-477

Snippet

Sponsor: REMD Biotherapeutics, Inc. | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2023-05-25